Skip to main content
Fig. 1 | BMC Research Notes

Fig. 1

From: The relationship between high ratios of CD4/FOXP3 and CD8/CD163 and the improved survivability of metastatic triple-negative breast cancer patients: a multicenter cohort study

Fig. 1

Impact of biomarker expression on 1 year OS of mTNBC patients A 1 year OS based on CD4 level. B 1 year OS based on CD8 level. C 1 year OS based on CD4/FOXP3 level. D 1 year OS based on CD8/ FOXP3 level. E 1 year OS based on CD8/ CD163 level. Survival curves were analyzed using Kaplan-Meier method and compared using log-rank test. OS overall survival, mTNBC metastatic triple-negative breast cancer.

Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us